Compare CVS Health Corp (CVS) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Seagate Technology Holdings PLC — how do they compare? CVS Health Corp trades at $86.2 (market cap $112.49B), while Seagate Technology Holdings PLC trades at $786.5 (market cap $183.64B). The key difference: Seagate Technology Holdings PLC is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Seagate Technology Holdings PLC for 41 Days on average.
| CVS | STX | |
|---|---|---|
Market Cap | $112.49B | $183.64B |
Volume | 8,467,392 | 4,409,190 |
Sector | Health | Technology |
52-Week High | $110.60 | $1.09K |
52-Week Low | $70.08 | $211.63 |
Typical Hold Time | 83 Days | 41 Days |
Enterprise Value | $174.83B | $185.79B |
Dividend Yield | 3.02% | 0.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
STX trades at $774.83, down 3.82% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $5.71 vs. $5.10, and robust profitability metrics including 26.11% net margin and 371.53% ROE. Technical indicators signal bearish momentum with price near support at $773, while analyst consensus remains positive with 53.85% buy ratings and $1,130 price target.
Despite near-term competitive pressures, STX maintains strong earnings momentum and leadership in AI storage markets. The primary risk involves Toshiba's capacity expansion potentially eroding pricing power, but projected 2026 revenue growth to $12.2B and net income of $3.2B support long-term upside. Current valuation at 58.1 P/E reflects growth expectations amid technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
